Gladstone Institutional Advisory’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-23,542	Closed	-$228K	–	614
2021 Q2	$228K	Buy	23,542 +101	+0.4%	+$978	0.03%	462
2021 Q1	$252K	Buy	+23,441	New	+$252K	0.04%	350
2020 Q4	–	Sell	-10,150	Closed	-$144K	–	326
2020 Q3	$144K	Buy	+10,150	New	+$144K	0.03%	257